368 related articles for article (PubMed ID: 21325637)
1. PDGF-induced vascular smooth muscle cell proliferation is associated with dysregulation of insulin receptor substrates.
Zhao Y; Biswas SK; McNulty PH; Kozak M; Jun JY; Segar L
Am J Physiol Cell Physiol; 2011 Jun; 300(6):C1375-85. PubMed ID: 21325637
[TBL] [Abstract][Full Text] [Related]
2. High fructose-mediated attenuation of insulin receptor signaling does not affect PDGF-induced proliferative signaling in vascular smooth muscle cells.
Osman I; Poulose N; Ganapathy V; Segar L
Eur J Pharmacol; 2016 Nov; 791():703-710. PubMed ID: 27729247
[TBL] [Abstract][Full Text] [Related]
3. Imatinib induces apoptosis by inhibiting PDGF- but not insulin-induced PI 3-kinase/Akt survival signaling in RGC-5 retinal ganglion cells.
Biswas SK; Zhao Y; Sandirasegarane L
Mol Vis; 2009 Aug; 15():1599-610. PubMed ID: 19693287
[TBL] [Abstract][Full Text] [Related]
4. Rapamycin promotes vascular smooth muscle cell differentiation through insulin receptor substrate-1/phosphatidylinositol 3-kinase/Akt2 feedback signaling.
Martin KA; Merenick BL; Ding M; Fetalvero KM; Rzucidlo EM; Kozul CD; Brown DJ; Chiu HY; Shyu M; Drapeau BL; Wagner RJ; Powell RJ
J Biol Chem; 2007 Dec; 282(49):36112-20. PubMed ID: 17908691
[TBL] [Abstract][Full Text] [Related]
5. Antiproliferative activity of NQ304, a synthetic 1,4-naphthoquinone, is mediated via the suppressions of the PI3K/Akt and ERK1/2 signaling pathways in PDGF-BB-stimulated vascular smooth muscle cells.
Kim TJ; Yun YP
Vascul Pharmacol; 2007 Jan; 46(1):43-51. PubMed ID: 16875883
[TBL] [Abstract][Full Text] [Related]
6. Ketamine, a Clinically Used Anesthetic, Inhibits Vascular Smooth Muscle Cell Proliferation via PP2A-Activated PI3K/Akt/ERK Inhibition.
Chang Y; Li JY; Jayakumar T; Hung SH; Lee WC; Manubolu M; Sheu JR; Hsu MJ
Int J Mol Sci; 2017 Nov; 18(12):. PubMed ID: 29186909
[TBL] [Abstract][Full Text] [Related]
7. Pioglitazone, a PPARγ agonist, attenuates PDGF-induced vascular smooth muscle cell proliferation through AMPK-dependent and AMPK-independent inhibition of mTOR/p70S6K and ERK signaling.
Osman I; Segar L
Biochem Pharmacol; 2016 Feb; 101():54-70. PubMed ID: 26643070
[TBL] [Abstract][Full Text] [Related]
8. Chicoric acid prevents PDGF-BB-induced VSMC dedifferentiation, proliferation and migration by suppressing ROS/NFκB/mTOR/P70S6K signaling cascade.
Lu QB; Wan MY; Wang PY; Zhang CX; Xu DY; Liao X; Sun HJ
Redox Biol; 2018 Apr; 14():656-668. PubMed ID: 29175753
[TBL] [Abstract][Full Text] [Related]
9. Sulfur dioxide inhibits vascular smooth muscle cell proliferation via suppressing the Erk/MAP kinase pathway mediated by cAMP/PKA signaling.
Liu D; Huang Y; Bu D; Liu AD; Holmberg L; Jia Y; Tang C; Du J; Jin H
Cell Death Dis; 2014 May; 5(5):e1251. PubMed ID: 24853429
[TBL] [Abstract][Full Text] [Related]
10. Zedoarondiol Inhibits Platelet-Derived Growth Factor-Induced Vascular Smooth Muscle Cells Proliferation via Regulating AMP-Activated Protein Kinase Signaling Pathway.
Mao H; Tao T; Song D; Liu M; Wang X; Liu X; Shi D
Cell Physiol Biochem; 2016; 40(6):1506-1520. PubMed ID: 27997894
[TBL] [Abstract][Full Text] [Related]
11. AMP-activated protein kinase inhibits IGF-I signaling and protein synthesis in vascular smooth muscle cells via stimulation of insulin receptor substrate 1 S794 and tuberous sclerosis 2 S1345 phosphorylation.
Ning J; Clemmons DR
Mol Endocrinol; 2010 Jun; 24(6):1218-29. PubMed ID: 20363874
[TBL] [Abstract][Full Text] [Related]
12. The integrin alpha2beta1 agonist, aggretin, promotes proliferation and migration of VSMC through NF-kB translocation and PDGF production.
Chung CH; Lin KT; Chang CH; Peng HC; Huang TF
Br J Pharmacol; 2009 Mar; 156(5):846-56. PubMed ID: 19239475
[TBL] [Abstract][Full Text] [Related]
13. Platelet-derived growth factor-BB, insulin-like growth factor-I, and phorbol ester activate different signaling pathways for stimulation of vascular smooth muscle cell migration.
Pukac L; Huangpu J; Karnovsky MJ
Exp Cell Res; 1998 Aug; 242(2):548-60. PubMed ID: 9683541
[TBL] [Abstract][Full Text] [Related]
14. Role of mTOR in the degradation of IRS-1: regulation of PP2A activity.
Hartley D; Cooper GM
J Cell Biochem; 2002; 85(2):304-14. PubMed ID: 11948686
[TBL] [Abstract][Full Text] [Related]
15. Synergistic roles of platelet-derived growth factor-BB and interleukin-1beta in phenotypic modulation of human aortic smooth muscle cells.
Chen CN; Li YS; Yeh YT; Lee PL; Usami S; Chien S; Chiu JJ
Proc Natl Acad Sci U S A; 2006 Feb; 103(8):2665-70. PubMed ID: 16477012
[TBL] [Abstract][Full Text] [Related]
16. Platelet-derived growth factor BB induces nuclear export and proteasomal degradation of CREB via phosphatidylinositol 3-kinase/Akt signaling in pulmonary artery smooth muscle cells.
Garat CV; Fankell D; Erickson PF; Reusch JE; Bauer NN; McMurtry IF; Klemm DJ
Mol Cell Biol; 2006 Jul; 26(13):4934-48. PubMed ID: 16782881
[TBL] [Abstract][Full Text] [Related]
17. Role of Src tyrosine kinases in experimental pulmonary hypertension.
Pullamsetti SS; Berghausen EM; Dabral S; Tretyn A; Butrous E; Savai R; Butrous G; Dahal BK; Brandes RP; Ghofrani HA; Weissmann N; Grimminger F; Seeger W; Rosenkranz S; Schermuly RT
Arterioscler Thromb Vasc Biol; 2012 Jun; 32(6):1354-65. PubMed ID: 22516066
[TBL] [Abstract][Full Text] [Related]
18. Chronic treatment with PDGF-BB and endothelin-1 synergistically induces vascular hyperplasia and loss of contractility in organ-cultured rat tail artery.
Kida T; Chuma H; Murata T; Yamawaki H; Matsumoto S; Hori M; Ozaki H
Atherosclerosis; 2011 Feb; 214(2):288-94. PubMed ID: 21129745
[TBL] [Abstract][Full Text] [Related]
19. Platelet-derived growth factor-BB (PDGF-BB) regulation of migration and focal adhesion kinase phosphorylation in rabbit aortic vascular smooth muscle cells: roles of phosphatidylinositol 3-kinase and mitogen-activated protein kinases.
Cospedal R; Abedi H; Zachary I
Cardiovasc Res; 1999 Mar; 41(3):708-21. PubMed ID: 10435043
[TBL] [Abstract][Full Text] [Related]
20. Sulforaphane inhibits platelet-derived growth factor-induced vascular smooth muscle cell proliferation by targeting mTOR/p70S6kinase signaling independent of Nrf2 activation.
Shawky NM; Segar L
Pharmacol Res; 2017 May; 119():251-264. PubMed ID: 28212891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
